Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia

Sykes, David B., Kfoury, Youmna S., Mercier, François E., Wawer, Mathias J., Law, Jason M., Haynes, Mark K., Lewis, Timothy A., Schajnovitz, Amir +22 more·2016·Cell
DOI 10.1016/j.cell.2016.08.057

Cited by (516)

Items 301–400 of 516

  1. Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
    Maximilian F. Stahl, Zachary Drew Epstein-Peterson, Andrew M. Intlekofer · 2020 · Cold Spring Harbor Perspectives in Medicine
  2. Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
    Lin Liu, Wenbin Mo, Miao Chen, Yi Qu, Pingping Wang, Ying Liang, Xiaojing Yan · 2024 · BMC Cancer
  3. Disruption of nucleotide biosynthesis reprograms mitochondrial metabolism to inhibit adipogenesis
    Julia A. Pinette, Jacob W. Myers, Woo Yong Park, Heather G. Bryant, Alex M. Eddie, Genesis A. Wilson, Claudia Montufar, Zayedali Shaikh, Zer Vue, Elizabeth R. Nunn et al. · 2024 · Journal of Lipid Research
  4. Combination decoction of Astragalus mongholicus and Salvia miltiorrhiza mitigates pressure-overload cardiac dysfunction by inhibiting multiple ferroptosis pathways
    Qiyao Xu, Xuan Liu, Zhaoyang Chen, Can Guo, Pengyu Lu, Sujie Zhang, Xindong Wang, Jianping Shen · 2024 · Frontiers in Pharmacology
  5. Dihydroorotate dehydrogenase inhibition activates STING pathway and pyroptosis to enhance NK cell-dependent tumor immunotherapy
    Yongrui Hai, Ruizhuo Lin, Weike Liao, Siqing Fu, Renming Fan, Guiquan Ding, Junyan Zhuang, Bingjie Zhang, Yi Liu, Jun-Ke Song et al. · 2025 · Molecular Biomedicine
  6. Mitochondrial Transfer Rescues Respiration to Support De Novo Pyrimidine Biosynthesis and Tumor Progression
    Maria Dubisova, Klára Boháčová, Zuzana Nahácka, Daniel Kraus, Jaromı́r Novák, Šárka Dvořáková, Petra Brisudová, Natalie Danesova, Saba Selvi, Mariia Hrysiuk et al. · 2025 · Cancer Research
  7. Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
    Ola A. Elgamal, Sydney Fobare, Sandip M. Vibhute, Abeera Mehmood, Dennis C. Vroom, Mariah L. Johnson, Blaise Stearns, James R. Lerma, Jean Truxall, Emily H. Stahl et al. · 2024 · JCI Insight
  8. FLT3-Mutated Leukemic Stem Cells: Mechanisms of Resistance and New Therapeutic Targets
    Debora Capelli · 2024 · Cancers
  9. The multienzymatic protein CAD leading the de novo biosynthesis of pyrimidines localizes exclusively in the cytoplasm and does not translocate to the nucleus
    Francisco del Caño‐Ochoa, Santiago Ramón‐Maiques · 2020 · Nucleosides Nucleotides & Nucleic Acids
  10. Harnessing the Metabolic Vulnerabilities of Leukemia Stem Cells to Eradicate Acute Myeloid Leukemia
    Bijender Kumar · 2021 · Frontiers in Oncology
  11. A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage
    Xiaowei Yang, Chungen Li, Kun Gou, Xiaocong Liu, Yue Zhou, Jiao Zou, Qiang Chen, Youfu Luo, Yinglan Zhao · 2022 · MedComm – Oncology
  12. Application of Metabolomics in Childhood Leukemia Diagnostics
    Agata Kozioł, Małgorzata Pupek · 2022 · Archivum Immunologiae et Therapiae Experimentalis
  13. Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines
    Laia Josa‐Culleré, Sébastien R. G. Galan, Thomas J. Cogswell, Thomas Jackson, Morgan Jay‐Smith, Laura Mola, Christopher R. Greaves, Tom S. Carter, Katrina S. Madden, Sophie Trott et al. · 2023 · European Journal of Medicinal Chemistry
  14. Genome-scale drop-out screens to identify cancer cell vulnerabilities in AML
    Faisal Basheer, George S. Vassiliou · 2019 · Current Opinion in Genetics & Development
  15. Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance
    Nick van Gastel, Jessica B. Spinelli, Azeem Sharda, Amir Schajnovitz, Ninib Baryawno, Catherine Rhee, Toshihiko Oki, Eliane Grace, Heather J. Soled, Charles Vidoudez et al. · 2020 · SSRN Electronic Journal
  16. In Vivo Chemical Screening in Zebrafish Embryos Identified FDA-Approved Drugs That Induce Differentiation of Acute Myeloid Leukemia Cells
    Xiaona Wei, Wei Wang, Qianlan Yin, Hongji Li, Abrar Ahmed, Rahat Ullah, Wei Li, Lili Jing · 2024 · International Journal of Molecular Sciences
  17. The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia
    Yang Li, Deyu Ma, Shan Liu, Lin Zou · 2024 · Annals of Hematology
  18. Assessment of a novel variation in DHODH gene causing Miller syndrome: The first report in Chinese population
    Kai Yang, Li‐Man Fu, Xiaoyang Chu, Jing Zhang, Wen‐qi Chen, Yousheng Yan, Yipeng Wang, Dongliang Zhang, Chenghong Yin, Qing Guo · 2023 · Molecular Genetics & Genomic Medicine
  19. Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
    Sudhamsh Reddy Desai, Samarpana Chakraborty, Aditi Shastri · 2023 · Best Practice & Research Clinical Haematology
  20. Discovery of Thiadiazoles as Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors by Combined Structure‐Based Modelling Methods
    Pinky Gehlot, Sunil Kumar, Vipin Kumar, Vivek Kumar Vyas · 2024 · ChemistrySelect
  21. DHODH Inhibition Suppresses MYC and Inhibits the Growth of Medulloblastoma in a Novel In Vivo Zebrafish Model
    Ιωάννα Τσέα, Thale Kristin Olsen, Panagiotis Alkinoos Polychronopoulos, Conny Tümmler, D. Sykes, Ninib Baryawno, Cecilia H. Dyberg · 2024 · Cancers
  22. A new target for differentiation therapy in AML
    Peilin Ma, Weihua Song, Jay L. Hess · 2016 · Cell Research
  23. Hydrophilic Realgar Nanocrystals Prolong the Survival of Refractory Acute Myeloid Leukemia Mice Through Inducing Multi-Lineage Differentiation and Apoptosis
    Tao Wang, Xue Zhang, Mengfan Jia, Aiyun Yang, Jian Liu, Tao Wen, Jie Meng, Haiyan Xu · 2022 · International Journal of Nanomedicine
  24. Site of breast cancer metastasis is independent of single nutrient levels
    Keene L. Abbott, Sonu Subudhi, Raphaël Ferreira, Yetiş Gültekin, Sophie Charlotte Steinbuch, Muhammad Bin Munim, Sophie Elisabeth Honeder, Ashwin Srinivasan Kumar, Diya L. Ramesh, Michelle Wu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Regenerating liver uses ammonia to support de novo pyrimidine synthesis and cell proliferation
    Berwini Endaya, Lukáš Kučera, Dan‐Diem Thi Le, Jessica B. Spinelli, Andrea Brožková, Dominika Luptáková, Kryštof Klíma, Gabriela Lopes Oliveira, Petra Brisudová, Klára Boháčová et al. · 2025 · Nature Communications
  26. Pan-cancer analysis of pyrimidine metabolism reveals signaling pathways connections with chemoresistance role
    Vignesh Ramesh, Mert Demirdizen, Luisa Pinna, Thomas Koed Doktor, Federica Benso, Aarif Siddiqui, Paolo Ceppi · 2025 · British Journal of Cancer
  27. Analysis of a model of dormancy in cancer as a state of coexistence between tumor and healthy stem cells
    Walid Djema, Catherine Bonnet, Jean Clairambault, Frédéric Mazenc, Pierre Hirsch, François Delhommeau · 2017 · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference
  28. Integrative Bioinformatics Analysis Reveals Possible Target and Mechanism of Ellipticine Against Breast Cancer Stem Cells.
    Adam Hermawan, Herwandhani Putri · 2021 · INDONESIAN JOURNAL OF PHARMACY
  29. Role of pH in Regulating Cancer Pyrimidine Synthesis
    Saad S. Alqahtani, Tomas Koltai, Muntaser Eltayeb Ibrahim, Adil H. H. Bashir, Sari T. S. Alhoufie, Samrein B. M. Ahmed, Daria Di Molfetta, Tiago M. A. Carvalho, Rosa Angela Cardone, Stephan J. Reshkin et al. · 2022 · Journal of Xenobiotics
  30. Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol
    Kristína Šimoničová, Ľuboš Janotka, Helena Kavcová, Zdena Sulová, Lucia Messingerová, Albert Breier · 2023 · Cancers
  31. Targeting DHODH reveals therapeutic opportunities in ATRA-resistant acute promyelocytic leukemia
    Tingyuan Yang, Xiayu Shi, Shiliang Li, Zhenjiang Zhao, Junyi Wang, Panpan Yu, Honglin Li, Rui Wang, Zhuo Chen · 2023 · Biomedicine & Pharmacotherapy
  32. Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome
    Juan Manuel Orozco Rodriguez, Ewa Krupinska, Hanna Pauliina Wacklin, Wolfgang Knecht · 2022 · Nucleosides Nucleotides & Nucleic Acids
  33. A multiomics approach reveals RNA dynamics promote cellular sensitivity to DNA hypomethylation
    Ge, Alex Y., Arab, Abolfazl, Dai, Raymond, Navickas, Albertas, Fish, Lisa, Garcia, Kristle, Asgharian, Hosseinali, Goudreau, Jackson, Lee, Sean, Keenan, Kathryn et al. · 2024 · Scientific Reports
  34. Metabolic instruction of the graft-versus-leukemia immunity
    Ann‐Cathrin Burk, Petya Apostolova · 2024 · Frontiers in Immunology
  35. OGFOD1 enables AML chemo- and nutrient stress resistance by regulating protein synthesis
    Christina Mayerhofer, Dan Li, Trine Ahn Kristiansen, Ernst Mayerhofer, Azeem Sharda, Giulia Schiroli, Karin Gustafsson, Lingli He, Michael Mazzola, Sam Keyes et al. · 2026 · Klinische Pädiatrie
  36. Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation
    Tianyi Ling, Cristiana O’Brien, Jonathan R. St‐Germain, Vincent Rondeau, Mary Y. Shi, Jacob M. Berman, Adrianna Kinga Cepa, Paula Saez Raez, Mark Wunderlich, Katharine Marie Carter et al. · 2025 · Blood
  37. An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agent
    Marta Alberti, Giulio Poli, Luca Broggini, Stefano Sainas, Menico Rizzi, Donatella Boschi, Davide M. Ferraris, Elena Martino, Stéfano Ricagno, Tiziano Tuccinardi et al. · 2024 · Acta Crystallographica Section D Structural Biology
  38. Decitabine with etoposide is effective in TP53 mutated myeloid tumors via overcoming differentiation block
    Jiexian Ma, Shunrong Sun, Yanhui Xie, Songlin Zhou, Min‐Hsien Wu, Xinyu Zuo, Mixue Xie, Xiaoqin Wang · 2025 · Blood Cancer Journal
  39. CD37 regulates the self-renewal of leukemic stem cells via integrin-mediated signaling in acute myeloid leukemia
    Jinyuan Lu, Lixin Lv, Xiaoxue Tian, Zheng Li, Yuting Ma, Nannan Li, Jian Wang, Guangming Wang, Yu Zeng, Wenjun Zhang et al. · 2025 · Stem Cell Reports
  40. Cytokine exposure mediates transcriptional activation of the orphan nuclear receptor Nur77 in hematopoietic cells
    Orsola di Martino, Haixia Niu, Gayla Hadwiger, Margaret A. Ferris, John Sutton Welch · 2021 · Journal of Biological Chemistry
  41. Bone marrow stromal cells enhance differentiation of acute myeloid leukemia induced by pyrimidine synthesis inhibitors
    Tomislav Smoljo, Hrvoje Lalić, Vilma Dembitz, Barbara Tomić, Josip Batinić, Radovan Vrḫovac, Antonio Bedalov, Dora Višnjić · 2024 · American Journal of Physiology-Cell Physiology
  42. Lifting the Differentiation Embargo
    Anne‐Louise Latif, Tessa L. Holyoake · 2016 · Cell
  43. Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase
    Fanxun Zeng, Lina Quan, Guantian Yang, Tiantian Qi, Letian Zhang, Shiliang Li, Honglin Li, Lili Zhu, Xiaoyong Xu · 2019 · Molecules
  44. Targeting pyrimidine metabolism for glioblastoma therapy
    Veerakumar Balasubramaniyan, Krishna Bhat · 2019 · Neuro-Oncology
  45. Pathogen-Induced Expression of OsDHODH1 Suggests Positive Regulation of Basal Defense Against Xanthomonas oryzae pv. oryzae in Rice
    Nkulu Rolly Kabange, Qari Muhammad Imran, Hyun-Ho Kim, Nay Chi Aye, Adil Hussain, Kyung‐Min Kim, Byung‐Wook Yun · 2020 · Agriculture
  46. The Influence of Mitochondrial Energy and 1C Metabolism on the Efficacy of Anticancer Drugs: Exploring Potential Mechanisms of Resistance
    Marika Frańczak, Isabel Toenshoff, Gerrit Jansen, Ryszard Tomasz Smolenski, Elisa Giovannetti, Godefridus J. Peters · 2022 · Current Medicinal Chemistry
  47. Asymmetric inheritance of cytoophidia could contribute to determine cell fate and plasticity
    Suhas Deoram Darekar, Sonia Laı́n · 2022 · BioEssays
  48. Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A) <sup>+</sup> RNA foci adjacent to nuclear speckles following activation of ATM (ataxia telangiectasia mutated)
    Miyake, Shuntaro, Masuda, Seiji · 2022 · RNA Biology
  49. Inhibition of DHODH Enhances Replication-Associated Genomic Instability and Promotes Sensitivity in Endometrial Cancer
    Shengyuan Zhao, Aaliyah Francois, Dawit Kidane · 2023 · Cancers
  50. Guanosine primes acute myeloid leukemia for differentiation via guanine nucleotide salvage synthesis.
    Hanying Wang, Xin He, Zheng Li, Hongchuan Jin, Xian Wang, Ling Li · 2022 · PubMed Central
  51. Predestined neutrophil heterogeneity in homeostasis varies in transcriptional and phenotypic response to Candida
    Allison K. Scherer, Alex R. Hopke, Shuying Xu, Adam L. Viens, Natalie J. Alexander, Kyle D. Timmer, Dakota Archambault, Daniel J. Floyd, Natalie J. Atallah, Catherine Rhee et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  52. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
    Nicholas J. Mullen, Surendra Kumar Shukla, Ravi Kumar Thakur, Sai Sundeep Kollala, Dezhen Wang, Nina V. Chaika, Juan F. Santana, William R. Miklavcic, Drew A. LaBreck, Jayapal Reddy Mallareddy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Cancer Therapies Targeting Cellular Metabolism
    Benjamin L. Morris, Alejandro Gutiérrez · 2024 · Cold Spring Harbor Perspectives in Medicine
  54. Pyrimidine metabolism reshapes immune microenvironment and implies poor prognosis in glioma
    Ruoyu Huang, Jingchen Yang, Xuejing Li, Huiyuan Chen, Xing Liu · 2024 · Clinical & Translational Oncology
  55. Transcriptomic changes and mitochondrial toxicity in response to acute and repeat dose treatment with brequinar in human liver and kidney in vitro models
    Tamara Meijer, Bas ter Braak, Liesanne Wolters, Steven J. Kunnen, Barira Islam, Ilinca Suciu, Iain B. Gardner, Oliver J. D. Hatley, Richard A. Currie, Barry J. Hardy et al. · 2025 · Toxicology in Vitro
  56. Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors
    L. Dousset, Ferial Khalife, Domitille Chalopin, Benjamin Dartigues, Fatima Naji, Walid Mahfouf, Elodie Muzotte, Benoît Rousseau, Nívea Dias Amoêdo, Stéphane Claverol et al. · 2025 · British Journal of Dermatology
  57. Reawakening Differentiation Therapy in Acute Myeloid Leukemia: A Comprehensive Review of ATRA-Based Combination Strategies
    Shinichiro Takahashi · 2026 · Current Oncology
  58. DHODH as a targetable metabolic Achilles’ heel for chemotherapy-resistant B-ALL
    Yuxuan Liu, Haowen Jiang, Jingjing Liu, Lucille Stuani, Milton J. Merchant, Astraea Jager, Abhishek Koladiya, Ti‐Cheng Chang, Pablo Domizi, Jolanda Sarno et al. · 2026 · Blood
  59. Leukemic stem cells as drivers of therapeutic resistance in acute myeloid leukemia
    Suellen L. R. Silva, Gabriela A. da C. Barbosa, João V.B. Rios, Daniel Pereira Bezerra · 2026 · Biomedicine & Pharmacotherapy
  60. Metabolism in Hematopoiesis and Its Malignancy
    Xiaoyuan Zeng, Yi-Ping Wang, Cheuk Him Man · 2023 · Advances in experimental medicine and biology
  61. Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia
    Patryk Firmanty, Monika Chomczyk, Shubhankar Dash, Marina Y Konopleva, Natalia Baran · 2024 · Current Pharmacology Reports
  62. Targeting vulnerability in tumor therapy: Dihydroorotate dehydrogenase
    Fu Lin, Jiaxin Li, Lei Zhou, Rigui Yi, Y Chen, Shuai He · 2025 · Life Sciences
  63. Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system
    Zhe Wang, Peilin Zou, Zhenzhong Chen, Jiahui Hou, You Lee Son, Daisuke Yamashita, Tôru Kondo · 2025 · British Journal of Cancer
  64. Targeting the Leukemic stem cell protein machinery by inhibition of mitochondrial pyrimidine synthesis
    Elisa Donato, Andreas Trumpp · 2022 · EMBO Molecular Medicine
  65. Hoxa9 / meis1 -transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance
    Wei Wang, Hongji Li, Mengling Huang, Xue Wang, Wei Li, Xiaoqing Qian, Lili Jing · 2022 · Open Biology
  66. Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
    Twana Alkasalias, Juan Zhang, Harsha S. Madapura, Basile Dalarun, Oscar Bedoya Reina, Rolf Lewensohn, Kristina Viktorsson, Abbas Burhan Salihi, Suhas Deoram Darekar, Sonia Laı́n · 2022 · Cell Death Discovery
  67. Clinical and laboratory effects of exchange transfusion in pediatric acute lymphoblastic leukemia with hyperleukocytosis
    Rasya Azka Lazuwardi, Mia Ratwita Andarsini, Yetti Hernaningsih · 2023 · Paediatrica Indonesiana
  68. Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH Inhibitors
    Lindsey G. DeRatt, E. Christine Pietsch, Justin S. Cisar, Edgar Jacoby, Faraz Kazmi, Rosalie Matico, Paul L. Shaffer, Alexandra Tanner, Weixue Wang, Ricardo M. Attar et al. · 2024 · ACS Medicinal Chemistry Letters
  69. A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation
    Luchen Sun, Shangrui Rao, Kamran Kerim, Hongzheng Li, Hongzheng Li, Shengsheng Zhao, Pingping Shen, Weijian Sun · 2024 · Biochemical Pharmacology
  70. Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression
    Zhijing Zhang, Xinglin Hu, Yuchen Sun, Lei Lei, Zhonghua Liu · 2024 · BMC Biology
  71. Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept
    Stefano Sainas, Elena Martino, Claudio Garino, Paola Circosta, Anna Luganini, Marta Giorgis, Francesco Bavo, Marco Piccinini, Cristina Ramondetti, Marta Alberti et al. · 2025 · Journal of Medicinal Chemistry
  72. Therapeutic strategies targeting somatic stem cells: Chemical approaches
    Yu Chen, Sheng Ding · 2020 · Bioorganic & Medicinal Chemistry
  73. PCK1 and DHODH drive colorectal cancer liver metastatic colonization and nucleotide biosynthesis under hypoxia
    Norihiro Yamaguchi, Ethan M. Weinberg, Alexander Nguyen, Maria V Liberti, Hani Goodarzi, Yelena Y Janjigian, Philip B Paty, Leonard B. Saltz, T Peter Kingham, Jia Min Loo et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Translational Pharmacokinetic-Pharmacodynamic Modeling of a Novel Oral Dihydroorotate Dehydrogenase (DHODH) Inhibitor, HOSU-53 (JBZ-001)
    Joo Young Na, Min Hai, Kyeongmin Kim, Sandip M. Vibhute, Chad E. Bennett, Christopher Charles Coss, Mitch A. Phelps · 2025 · Pharmaceutics
  75. Design, synthesis and biological evaluation of N -pyridinyl ureidobenzenesulfonates and their hydrochloride salts as novel water-soluble dihydroorotate dehydrogenase inhibitors inducing differentiation of acute myeloid leukemia cells
    Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, Geneviève Hamel-Côté, Sébastien Fortin · 2025 · RSC Medicinal Chemistry
  76. Fluorinated small molecule derivatives in cancer immunotherapy: emerging frontiers and therapeutic potential
    Ka Fai Leong, Zihan Chen, Paolo Saul Coghi · 2025 · Frontiers in Immunology
  77. PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis
    Parmanand Malvi, Suresh Bugide, Roshan Kumar Dutta, Kiran Kumar Reddi, Yvonne J. K. Edwards, Kamaljeet Singh, Romi Gupta, Narendra Wajapeyee · 2025 · Cell Reports Medicine
  78. Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity
    Marta Alberti, Martina Tamburello, Stefano Salamone, Giorgio Gallinella, Cinzia Sanna, Giovanni Appendino, Marco L. Lolli, Alberto Massarotti, Federica Pollastro, Riccardo Miggiano · 2025 · Journal of Natural Products
  79. Identification and Preliminary Structure-Activity Relationship Studies of 1,5-Dihydrobenzo[e][1,4]oxazepin-2(3H)-ones That Induce Differentiation of Acute Myeloid Leukemia Cells In Vitro
    Laia Josa‐Culleré, Thomas J. Cogswell, Irene Georgiou, Morgan Jay‐Smith, Thomas Jackson, Carole J. R. Bataille, Stephen G. Davies, Paresh Vyas, Thomas A. Milne, Graham M. Wynne et al. · 2021 · Molecules
  80. Inhibition of pyrimidine biosynthesis by strobilurin derivatives induces differentiation of acute myeloid leukemia cells
    Xing Shen, Lu Zhang, Shuang Jun Xing, Xuewen Zhang, Guo-Lin Xiong, Yuwen Cong, He Xiao, Xinru Wang, Zu‐Yin Yu · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  81. IPP/CNRS-A017: A chemical probe for human dihydroorotate dehydrogenase (hDHODH)
    Andreas Krämer, Amelie Tjaden, Benardina Ndreshkjana, Claudia Tredup, Henner F. Farin, Stefan Knapp, Yves Louis Janin, Susanne Müller · 2022 · Current Research in Chemical Biology
  82. Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage
    Tanzina Mollick, Suhas Deoram Darekar, Basile Dalarun, Flavia Plastino, Juan Zhang, Andrés Pastor Fernández, Twana Alkasalias, Helder André, Sonia Laı́n · 2023 · Heliyon
  83. Discovery of Nanomolar Inhibitors for Human Dihydroorotate Dehydrogenase Using Structure-Based Drug Discovery Methods
    William T. Higgins, Sandip M. Vibhute, Chad E. Bennett, Steffen Lindert · 2024 · Journal of Chemical Information and Modeling
  84. N-Phenyl ureidobenzenesulfonates, a novel class of human dihydroorotate dehydrogenase inhibitors inducing differentiation and apoptosis in acute myeloid leukemia cells
    Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, Vincent Ouellette, Mathieu Gagné‐Boulet, Geneviève Hamel-Côté, Dominic Bastien, Isabelle Laverdière, Sébastien Fortin · 2024 · Biomedicine & Pharmacotherapy
  85. Metabolic pathway analysis of tumors using stable isotopes
    Qiufen Bi, Junzhang Zhao, Jun Hui Nie, Fang Huang · 2025 · Seminars in Cancer Biology
  86. The Histone Chaperone CAF-1 Sustains Myeloid Lineage Identity
    Yiming Guo, Fei Ji, Jernej Murn, David Eugene Frankhouser, M. Andrés Blanco, Carmen Chiem, MiHyun Jang, Ruslan I. Sadreyev, Russell C. Rockne, David B. Sykes et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  87. A phenotypic screen identifies a compound series that induces differentiation of acute myeloid leukemia cells in vitro and shows anti-tumour effects in vivo
    Laia Josa‐Culleré, Katrina S. Madden, Thomas J. Cogswell, Thomas Jackson, Tom S. Carter, Douzi Zhang, Graham P. Trevitt, Stephen G. Davies, Paresh Vyas, Graham M. Wynne et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  88. A novel tubulin binding molecule drives differentiation of acute myeloid leukaemia cells
    Thomas Jackson, Aini Vuorinen, Laia Josa‐Culleré, Katrina S. Madden, Daniel Conole, Thomas J. Cogswell, Isabel V. L. Wilkinson, Laura M. Kettyle, Douzi Zhang, Alison O’Mahony et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance
    N. van Gastel, J. Spinelli, A. Sharda, A. Schajnovitz, N. Baryawno, Catherine Rhee, T. Oki, E. Grace, Heather J. Soled, Jelena Milošević et al. · 2020 · Cell Metabolism
  90. Regulation of RNA methylation by therapy treatment, promotes tumor survival
    Syed I. A. Bukhari, Samuel Spencer Truesdell, Chandreyee Datta, Pritha Choudhury, Keith Q. Wu, Jitendra Shrestha, Ruby Maharjan, Ethan Plotsker, Ramzi K. Elased, Sadia Laisa et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
    Nicholas J. Mullen, Surendra Kumar Shukla, Ravi Kumar Thakur, Sai Sundeep Kollala, Dezhen Wang, Nina V. Chaika, Juan F. Santana, William R. Miklavcic, Drew A. LaBreck, Jayapal Reddy Mallareddy et al. · 2024 · eLife
  92. Uridine Metabolism as a Targetable Metabolic Achilles’ Heel for chemo-resistant B-ALL
    Yuxuan Liu, Haowen Jiang, Jingjing Liu, Lucille Stuani, Milton J. Merchant, Astraea Jager, Abhishek Koladiya, Ti‐Cheng Chang, Pablo Domizi, Jolanda Sarno et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Riboflavin drives nucleotide biosynthesis and iron-sulfur metabolism to promote acute myeloid leukemia
    Stefan Bjelosevic, Rahel Fauth, Brian T. Do, Gabriela Alexe, Lucy A. Merickel, Thomas Daniel Jackson, Allen Thayakumar Basanthakumar, Audrey Taillon, Silvi Salhotra, Birgitta A. Ryback et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Identification of isoquinolinone DHODH inhibitor isosteres
    Lindsey G. DeRatt, Zhuming Zhang, E. Christine Pietsch, Justin S. Cisar, Aihua Wang, Chaoyuan Wang, Alexandra Tanner, Paul L. Shaffer, Edgar Jacoby, Faraz Kazmi et al. · 2024 · Bioorganic & Medicinal Chemistry Letters
  95. Norchelerythrine from Corydalis incisa (Thunb.) Pers. promotes differentiation and apoptosis by activating DNA damage response in acute myeloid leukemia
    Jieun Lee, Byeol-Eun Jeon, Chan-Seong Kwon, Hyeon-Young Kim, Tae‐Jin Kim, Youngseob Seo, Sang Kook Lee, Ho‐Jin Shin, Sang-Woo Kim · 2025 · International Journal of Oncology
  96. Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice
    Milan R. Savani, Bingbing Li, Bailey C. Smith, Wen Gu, Yi Xiao, Gerard Baquer, Tracey E. Shipman, Skyler Oken, Namya Manoj, Lauren G. Zacharias et al. · 2026 · Nature Metabolism
  97. Elucidating the risk factors and oncogene drivers of acute myeloid leukemia
    Daniel Ruben Akiola Sanya, Djamila Onésime · 2025 · Human Cell
  98. Targeting opportunities presented by the pyrimidine biosynthesis pathway in Mycobacterium tuberculosis: a brief review
    Marta Alberti, Riccardo Miggiano · 2026 · Biochemical Society Transactions
  99. BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia
    Florian Robert, Cherif Badja, Soraya Boushaki, Andrea Degasperi, Yasin Memari, Sophie Momen, Theodoros I. Roumeliotis, Zuza Kozik, Malgorzata Gozdecka, Jyoti Sharma Choudhary et al. · 2026 · Annals of Hematology
  100. DHODH links mitochondrial bioenergetics, one-carbon metabolism, and DNA repair to sustain aggressive prostate adenocarcinoma
    R. Saiswaroop, Danthasinghe Waduge Badrajee Piyarathna, Ranjit Kumar Mehta, Venugopala Reddy Mekala, Jun Hyoung Park, Uttam Rasaily, Vani Venkatappa, Karthik Reddy Kami Reddy, Vasanta Putluri, Kaveri Goel et al. · 2026 · Cell Communication and Signaling